Zach Weinberg

Co-Founder & CEO, Curie.Bio · 1 appearance on the record.

computed by AI from the episodes · how this works → · full disclaimer →

founderinvestorexecutiveoperator@zachweinberg ↗

Zach Weinberg is the co-founder and CEO of Curie.Bio and a general partner at Operator Partners. He previously co-founded Invite Media, which was acquired by Google, and Flatiron Health, which was acquired by Roche.

22statements → 10claims → 5claims resolved → 20%fully supported → 4/5average certainty → 1.64/5average debate potential → ≈4.5/5argument clarity, estimated → 2said about them ↓

1 supported 3 partly supported 1 contradicted 5 not checkable as stated how the 10 claims stand · each chip opens the sources

2 predictions · 8 assertions · 4 insights · 8 disclosures · every statement was checked. The predictions and assertions are the 10 claims: statements the public record can support or contradict. 5 are resolved, and 5 name no date, number or outcome precise enough to check. Everything else (opinions, insights, what ifs, disclosures) can never be settled by the record, so it carries no assessment.

The record, in short

What the tape says about how Zach argues and how the claims held up. Everything they said, and everything said about them, is in the tabs below.

Their most notable supported claim

Assertion Supported
Flatiron Health partnered with NCCN's 25 major US cancer centers
“We announced a partnership with this group called the NCCN, which is the National Comprehensive Cancer Network. It's 25 of the largest cancer centers in the US where if you contribute your data you will be able to get the broader data set for research purposes…”
Zach Weinberg Feb 18, 2015 ▶ 7:01 Zach Weinberg, Flatiron Health // Using Data to Cure Cancer // Data Driven NYC (FirstMark Capital)

Their most notable contradicted claim

Prediction Didn’t hold up
US oncology EHR adoption will reach 100% by 2017
“And in oncology that's about 90% or so, and growing. It'll be a hundred percent within the next two years.”
Zach Weinberg Feb 18, 2015 ▶ 4:53 Zach Weinberg, Flatiron Health // Using Data to Cure Cancer // Data Driven NYC (FirstMark Capital)

Expressed certainty vs assessment result

none yet certainty 1
none yet certainty 2
none yet certainty 3
50% certainty 4
50% certainty 5

weighted support: a fully supported claim counts one, a partly supported claim counts half. Each filled bar is clickable and opens exactly those claims; "none yet" means nothing said at that certainty level has resolved yet

How they sound: speaking style how? →

260 words/min while actually speaking · 39.8 um and uh per 1k words

No argument clarity score for Zach Weinberg: only 7 usable question→answer exchanges on raw tape (a fair score needs 8+). We do not score a sample that small. Roundtable and news formats yield far fewer direct exchanges than interviews. Their coarse estimate from 7 raw tape exchanges is ≈4.5/5, shown at half point precision because the sample is small.

Measured by listening to the audio itself: 4,947 words across 1 episode of raw-level tape, transcribed verbatim with every um and uh kept, each one attributed only where the alignment onto our timed stream is unambiguous. These are measurements of speaking style. We do not rank them: across this corpus, fluency and argument quality are nearly uncorrelated (ρ≈0.2), and smooth talking does not signal clear thinking. How it's measured →

Everything Zach Weinberg said on the MAD Podcast that made the record, most notable first. Filter by type, assessment or year in the ledger →

Prediction Not checkable as stated
Doctors will not change workflows within a startup's timeframe
“Doctors are not going to change. And at least not in any sort of timeframe that matters for a startup. Maybe, maybe 1015 years.”
Zach Weinberg Feb 18, 2015 ▶ 10:58 Zach Weinberg, Flatiron Health // Using Data to Cure Cancer // Data Driven NYC (FirstMark Capital)
Assertion Not checkable as stated
Flatiron captures EGFR mutation status in 99% of its dataset
“If you looked for that in a structured field, you'd see it about nine or 10% of the time. In our data set, it's 99%.”
Zach Weinberg Feb 18, 2015 ▶ 10:04 Zach Weinberg, Flatiron Health // Using Data to Cure Cancer // Data Driven NYC (FirstMark Capital)
Insight
EMRs are built for billing and workflow, not population health
“EMRs, including our own, we're no better, are built for physician workflow and billing. They're not built for population health or informatics or all this”
Zach Weinberg Feb 18, 2015 ▶ 12:25 Zach Weinberg, Flatiron Health // Using Data to Cure Cancer // Data Driven NYC (FirstMark Capital)
Insight
Machine learning should enhance human experts rather than replace them
“Our take on this is we should be building tools for trained professionals along with a feedback loop to tell them how they're doing. Machine learning and other technologies I think you can apply on top to make those people slightly more efficient.”
Zach Weinberg Feb 18, 2015 ▶ 13:43 Zach Weinberg, Flatiron Health // Using Data to Cure Cancer // Data Driven NYC (FirstMark Capital)
Assertion Not checkable as stated
Most under-20 person healthcare startups fail to cross the scaling chasm
“There's a hell of a lot of 20 people and under healthcare startups coming out of incubators and whatnot, but most, if you look at the success, and not to, Poo poo startups, but most fail to cross that chasm into, like, a successful healthcare business.”
Zach Weinberg Feb 18, 2015 ▶ 14:37 Zach Weinberg, Flatiron Health // Using Data to Cure Cancer // Data Driven NYC (FirstMark Capital)
Insight
Ask for advice rather than pitching during early customer discovery
“Our tip and trick for this was always just to ask for advice. Pretend like you're not actually selling something so people enjoy giving feedback they don't like being sold to.”
Zach Weinberg Feb 18, 2015 ▶ 2:08 Zach Weinberg, Flatiron Health // Using Data to Cure Cancer // Data Driven NYC (FirstMark Capital)
Assertion Partly supported
Flatiron raised $138M from Google, its largest healthcare deal
“We, we've raised about a hundred and thirty eight million dollars from Google. We're their largest healthcare investment to date.”
Zach Weinberg Feb 18, 2015 ▶ 3:01 Zach Weinberg, Flatiron Health // Using Data to Cure Cancer // Data Driven NYC (FirstMark Capital)
Assertion Not checkable as stated
Flatiron Health software connects 20% of US cancer cases
“And that network now represents about 20% of all cancer cases in the U.S. So about one in five cancer cases we see.”
Zach Weinberg Feb 18, 2015 ▶ 4:00 Zach Weinberg, Flatiron Health // Using Data to Cure Cancer // Data Driven NYC (FirstMark Capital)
Prediction Didn’t hold up
US oncology EHR adoption will reach 100% by 2017
“And in oncology that's about 90% or so, and growing. It'll be a hundred percent within the next two years.”
Zach Weinberg Feb 18, 2015 ▶ 4:53 Zach Weinberg, Flatiron Health // Using Data to Cure Cancer // Data Driven NYC (FirstMark Capital)
Disclosure
Flatiron spends 90% of its time on single-player software value
“Today we've spent probably 90% of our time focused on the single player use case.”
Zach Weinberg Feb 18, 2015 ▶ 6:45 Zach Weinberg, Flatiron Health // Using Data to Cure Cancer // Data Driven NYC (FirstMark Capital)
Disclosure
Flatiron Health spent over half its $130M Series B acquiring an EHR
“We raised a Series B is a hundred and thirty million and we used some of that money you know, more than 50%, let's say, to acquire this electronic health records company that builds a specialized oncology EHR.”
Zach Weinberg Feb 18, 2015 ▶ 17:24 Zach Weinberg, Flatiron Health // Using Data to Cure Cancer // Data Driven NYC (FirstMark Capital)
Insight
Changing physician behavior requires showing direct benefits to individual doctors
“If you're gonna tell a doctor to change something they're doing, you need to tell them why it matters. And I think the key is explaining, hey, if you do this thing that you haven't done, and you weren't trained to do, and you went to school for, like, 15 years…”
Zach Weinberg Feb 18, 2015 ▶ 21:43 Zach Weinberg, Flatiron Health // Using Data to Cure Cancer // Data Driven NYC (FirstMark Capital)
Disclosure
Flatiron Health does not utilize health information exchanges
“We don't do health information exchanges, actually.”
Zach Weinberg Feb 18, 2015 ▶ 27:45 Zach Weinberg, Flatiron Health // Using Data to Cure Cancer // Data Driven NYC (FirstMark Capital)
Disclosure
Flatiron Health extracts clinical interpretations from reports, avoiding raw medical images
“So we don't pull the raw image today because for us it's about the clinical interpretation, and so that we get out of the report.”
Zach Weinberg Feb 18, 2015 ▶ 29:29 Zach Weinberg, Flatiron Health // Using Data to Cure Cancer // Data Driven NYC (FirstMark Capital)
Assertion Partly supported
Flatiron Health sees data from under 700,000 cancer patients annually
“We see a little under 700,000.”
Zach Weinberg Feb 18, 2015 ▶ 5:54 Zach Weinberg, Flatiron Health // Using Data to Cure Cancer // Data Driven NYC (FirstMark Capital)
Assertion Supported
Flatiron Health partnered with NCCN's 25 major US cancer centers
“We announced a partnership with this group called the NCCN, which is the National Comprehensive Cancer Network. It's 25 of the largest cancer centers in the US where if you contribute your data you will be able to get the broader data set for research purposes…”
Zach Weinberg Feb 18, 2015 ▶ 7:01 Zach Weinberg, Flatiron Health // Using Data to Cure Cancer // Data Driven NYC (FirstMark Capital)
Disclosure
Flatiron Health spends most of its operational time cleaning dirty data
“We talk about all the fun software, but the reality is we spend most of our time cleaning data.”
Zach Weinberg Feb 18, 2015 ▶ 7:49 Zach Weinberg, Flatiron Health // Using Data to Cure Cancer // Data Driven NYC (FirstMark Capital)
Disclosure
Flatiron tracks a 6,000-person lung cancer cohort monthly
“To do it at scale, we track a 6000 person advanced non-small cell lung cancer cohort every month.”
Zach Weinberg Feb 18, 2015 ▶ 10:19 Zach Weinberg, Flatiron Health // Using Data to Cure Cancer // Data Driven NYC (FirstMark Capital)
Assertion Not checkable as stated
Acquiring an oncology EHR saved three to five years on Flatiron's roadmap
“We probably shaved like three, four, five years off of our roadmap.”
Zach Weinberg Feb 18, 2015 ▶ 18:03 Zach Weinberg, Flatiron Health // Using Data to Cure Cancer // Data Driven NYC (FirstMark Capital)
Assertion Partly supported
Oncology accounts for about 40% of pharma R&D spending
“So about 40% of all R&D spending from pharma is oncology based.”
Zach Weinberg Feb 18, 2015 ▶ 19:48 Zach Weinberg, Flatiron Health // Using Data to Cure Cancer // Data Driven NYC (FirstMark Capital)
Disclosure
Flatiron's business is 60% provider-focused and 40% life sciences
“And right now about 60% of our business is, is provider focused, and then the other 40% Is, ah, research and life sciences focused.”
Zach Weinberg Feb 18, 2015 ▶ 24:06 Zach Weinberg, Flatiron Health // Using Data to Cure Cancer // Data Driven NYC (FirstMark Capital)
Disclosure
Flatiron targets data from the 95% of cancer patients outside trials
“So we don't touch that piece of the market. That's about four to five percent of patients will go on a trial. We look at the 95% who are not on a trial.”
Zach Weinberg Feb 18, 2015 ▶ 25:42 Zach Weinberg, Flatiron Health // Using Data to Cure Cancer // Data Driven NYC (FirstMark Capital)

The other half of the tape: Zach Weinberg's own voice is left out of every number here. Other people bring the name up 2 times in 1 episode on the MAD Podcast. every mention, with the transcript →

Who brings them up most Matt Turck 2

Every mention by year

tap a year for its mentions
0011212018episodesmentions
0112018episodes it came up in
0010.5212018episodesmentions per episode

Appearances (1)

EpisodeDateSpeaking time
Zach Weinberg, Flatiron Health // Using Data to Cure Cancer // Data Driven NYC (FirstMark Feb 18, 2015 22m
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 400 conversations transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.